Organization
CHA Vaccine Institute
5 clinical trials
Clinical trial
A Randomized, Open-labelled, Parallel, Phase 1 Clinical Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the Hepatitis B Vaccine CVI-HBV-002 in AdultsStatus: Completed, Estimated PCD: 2023-09-25
Clinical trial
A Randomized, Double-blinded, Placebo-controlled, Parallel, Multicenter, Phase 2b Study to Evaluate the Efficacy and Safety of CVI-HBV-002 in Patients With Chronic Hepatitis B Taking TenofovirStatus: Completed, Estimated PCD: 2023-12-04
Clinical trial
A Multicenter, Active-controlled, Open-label Phase I Study to Assess Safety and Tolerability and to Explore Immunogenicity of CVI-VZV-001 Vaccine in Healthy Adults Aged 50 to 64 YearsStatus: Recruiting, Estimated PCD: 2025-03-21
Clinical trial
A Single Center, Open Labeled Phase I/IIa Study to Evaluate Safety, Tolerability and Efficacy of a Therapeutic Hepatitis B Vaccine in Oral Antiviral Drug-treated Chronic Hepatitis B Virus CarriersStatus: Completed, Estimated PCD: 2017-08-22
Clinical trial
A Single Center, Randomized, Double Blinded PhaseI/IIa Exploratory Study to Evaluate Reactogenicity, Safety, Immunogenicity and Dose Response of a New Hepatitis B Vaccine in Human AdultStatus: Completed, Estimated PCD: 2015-05-28